Researchers from North Carolina State University have engineered designer biosensors that can detect antibiotic molecules of interest. The biosensors are a first step toward creating antibiotic-producing “factories” within microbes such as E. coli.
Macrolides are a group of naturally occurring small molecules that can have antibiotic, antifungal or anticancer effects. The antibiotic erythromycin is one example – it is a macrolide produced by soil-dwelling bacteria. Researchers are interested in using these natural antibiotics and the microbes that produce them in order to develop new antibiotics; however, microbes that produce antibiotic macrolides only make small amounts of a limited variety of antibiotics.
“Our ultimate goal is to engineer microbes to make new versions of these antibiotics for our use, which will drastically reduce the amount of time and money necessary for new drug testing and development,” says Gavin Williams, associate professor of bio-organic chemistry at NC State and corresponding author of a paper describing the research. “In order to do that, we first need to be able to detect the antibiotic molecules of interest produced by the microbes.”
Williams and his team used a naturally occurring molecular switch – a protein called MphR – as their biosensor. In E. coli, MphR can detect the presence of macrolide antibiotics being secreted by microbes that are attacking E. coli. When MphR senses the antibiotic, it turns on a resistance mechanism to negate the antibiotic’s effects.
The researchers created a large library of MphR protein variants and screened them for the ability to switch on production of a fluorescent green protein when they were in the presence of a desired macrolide. They tested the variants against erythromycin, which MphR already recognizes, and found that some of the MphR variants improved their detection ability tenfold. They also successfully tested the variants against macrolides that were not closely related to erythromycin, such as tylosin.
“Essentially we have co-opted and evolved the MphR sensor system, increasing its sensitivity in recognizing the molecules that we’re interested in,” says Williams. “We know that we can tailor this biosensor and that it will detect the molecules we’re interested in, which will enable us to screen millions of different strains quickly. This is the first step toward high-throughput engineering of antibiotics, where we create vast libraries of genetically modified strains and variants of microbes in order to find the few strains and variants that produce the desired molecule in the desired yield.”
Learn more: Designer Biosensor Can Detect Antibiotic Production by Microbes
The Latest on: Antibiotics
[google_news title=”” keyword=”antibiotics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- 27% of ED visits tied to inappropriate antibiotics, study suggestson May 17, 2024 at 10:40 am
Researchers found 27.6% of visits resulted in inappropriate antibiotic prescribing. Of these, 54% had diagnoses where antibiotics may have been wrongly prescribed, while 46% involved conditions ...
- Govt lens on misuse of antibiotics, DCGI seeks report within 2 weekson May 17, 2024 at 10:16 am
This comes in the backdrop of excessive and irrational use of antibiotics in India which fail to work in patients when they are routinely exposed to these drugs.
- What to know about MeCure, the company set to produce Nigeria’s first antibioticson May 17, 2024 at 8:23 am
Mecure Industries Plc, a pharmaceutical company in Nigeria, has revealed that it has secured approval from NAFDAC to launch the ...
- Australia’s Recce, Etana team up to develop synthetic antibiotics in Indonesiaon May 16, 2024 at 5:00 pm
Signed in February, the agreement aims to develop the new class of antibiotics to address the growing issue of drug-resistant superbugs, which can cause previously treatable infectious diseases to ...
- Suppressive Antibiotics for Joint Infections: Benefit Debate Unveiledon May 16, 2024 at 9:00 am
BENEFITS of suppressive antibiotic therapy (SAT) may be limited, according to new research. SAT is a routine strategy for managing periprosthetic joint infections (PJI), but determining the optimal ...
- Navamedic ASA: Renewed contract for delivering antibiotics to Norwegian hospitalson May 15, 2024 at 8:33 pm
The contract is awarded by The Norwegian Hospital Procurement Trust on behalf of the four health regions in Norway as part of the LIS tender programme (in Norwegian: legemiddelinnkjøpssamarbeid) for ...
- Woman becoming resistant to antibiotics after UTIson May 15, 2024 at 2:54 pm
A woman who needs antibiotics almost every other month says her growing resistance to them has caused "stress and suffering". Sian Jones, from Vale of Glamorgan, has spoken about her experience to ...
- Fungal foray-ing and the search for new antibioticson May 15, 2024 at 10:38 am
Could the answer to one of our most pressing health needs be hiding in Aotearoa’s bush? On Our Changing World this week, Liz Garton heads out on a foray to discover some of our fungal gems, and she ...
- New bacteria breakthrough may make existing antibiotics more effectiveon May 15, 2024 at 1:50 am
Microbiologists at Queen’s University have made a breakthrough in bacteria research which could lead to increased effectiveness of currently available antibiotics, helping in the global fight against ...
- Systemic Antibiotics in First Year of Life Tied to Higher Atopic Dermatitis Riskon May 8, 2024 at 11:30 pm
Systemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis (AD) risk in a dose-response fashion, according to a study published online April 24 in the Journal ...
via Google News and Bing News